Scribd Logo
Upload

Welcome to Scribd!

  • Notice: Registration Revocations, Restrictions, Denials, Reinstatements: Dade Behring, Inc.

    Uploaded by

    Justia.com
    17 views1 page
    Notice: Registration revocations, restrictions, denials, reinstatements: Dade Behring, Inc., 71559 [E5-6603] Drug Enforcement Administration

    Original Title

    Notice: Registration revocations, restrictions, denials, reinstatements: Dade Behring, Inc.

    Copyright

    © Public Domain

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Notice: Registration revocations, restrictions, denials, reinstatements: Dade Behring, Inc., 71559 [E5-6603] Drug Enforcement Administration

    Copyright:

    Public Domain
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    17 views1 page

    Notice: Registration Revocations, Restrictions, Denials, Reinstatements: Dade Behring, Inc.

    Uploaded by

    Justia.com
    Notice: Registration revocations, restrictions, denials, reinstatements: Dade Behring, Inc., 71559 [E5-6603] Drug Enforcement Administration

    Copyright:

    Public Domain
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Federal Register / Vol. 70, No.

    228 / Tuesday, November 29, 2005 / Notices 71559

    may file comments or objections to the Washington, DC 20537, Attention: DEA Alexandria, Virginia 22301; and must be
    issuance of the proposed registration Federal Register Representative, Liaison filed no later than January 30, 2006.
    pursuant to 21 CFR 1301.33(a). and Policy Section (ODL); or any being Dated: November 18, 2005.
    Any such written comments or sent via express mail should be sent to
    objections being sent via regular mail Joseph T. Rannazzisi,
    DEA Headquarters,
    may be addressed, in quintuplicate, to Attention: DEA Federal Register Acting Deputy Assistant Administrator, Office
    the Deputy Assistant Administrator, Representative/ODL, 2401 Jefferson of Diversion Control, Drug Enforcement
    Office of Diversion Control, Drug Administration.
    Davis Highway, Alexandria, Virginia
    Enforcement Administration, 22301; and must be filed no later than [FR Doc. E5–6605 Filed 11–28–05; 8:45 am]
    Washington, DC 20537, Attention: DEA January 30, 2006. BILLING CODE 4410–09–P
    Federal Register Representative, Liaison
    Dated: November 18, 2005.
    and Policy Section (ODL); or any being
    sent via express mail should be sent to Joseph T. Rannazzisi, DEPARTMENT OF JUSTICE
    DEA Headquarters, Attention: DEA Acting Deputy Assistant Administrator, Office
    Federal Register Representative/ODL, of Diversion Control, Drug Enforcement Drug Enforcement Administration
    Administration.
    2401 Jefferson Davis Highway,
    Alexandria, Virginia 22301; and must be [FR Doc. E5–6603 Filed 11–28–05; 8:45 am] Manufacturer of Controlled
    filed no later than January 30, 2006. BILLING CODE 4410–09–P Substances; Notice of Application
    Dated: November 18, 2005.
    Pursuant to Section 1301.33(a) of Title
    Joseph T. Rannazzisi, DEPARTMENT OF JUSTICE 21 of the Code of Federal Regulations
    Acting Deputy Assistant Administrator, Office (CFR), this is notice that on August 10,
    of Diversion Control, Drug Enforcement Drug Enforcement Administration
    Administration.
    2005, ISP, Freetown Fine Chemicals,
    Manufacturer of Controlled Inc., 238 South Main Street, Assonet,
    [FR Doc. E5–6602 Filed 11–28–05; 8:45 am]
    Substances; Notice of Application Massachusetts 02702, made application
    BILLING CODE 4410–09–P
    by renewal to the Drug Enforcement
    Pursuant to Section 1301.33(a) of Title Administration (DEA) for registration as
    DEPARTMENT OF JUSTICE 21 of the Code of Federal Regulations a bulk manufacturer of the basic classes
    (CFR), this is notice that on May 13, of controlled substances listed in
    Drug Enforcement Administration 2005, Dade Behring, Inc., Regulatory Schedules I and II:
    Affairs, Quality Systems, 20400 Mariani
    Manufacturer of Controlled Avenue, Cupertino, California 95014, Drug Schedule
    Substances; Notice of Application made application by renewal to the
    Drug Enforcement Administration 2,5-Dimethoxyamphetamine I
    Pursuant to Section 1301.33(a) of Title (7396).
    (DEA) for registration as a bulk
    21 of the Code of Federal Regulations Amphetamine (1100) .................. II
    manufacturer of the basic classes of
    (CFR), this is notice that on April 18, Phenylacetone (8501) ................ II
    controlled substances listed in Schedule
    2005, Dade Behring Inc., 100 GBE Drive,
    I and II:
    MS514, Post Office Box 6101, Attention:
    RA/QS, Newark, Delaware 19714–6101, The company plans to manufacture
    Drug Schedule phenylacetone to be used in the
    made application by renewal to the
    Drug Enforcement Administration Tetrahydrocannabionols (7370) ... I
    manufacture of amphetamine for
    (DEA) to be registered as a bulk Benzoylecgonine (9180) ............... II distribution to its customers. The bulk
    manufacturer of the basic classes of Morphine (9300) ........................... II 2,5-dimethoxyamphetamine will be
    controlled substances listed in used for conversion into non-controlled
    Schedules I and II: The company plans to produce the substances.
    listed controlled substances in bulk to Any other such applicant and any
    Drug Schedule be used in the manufacture of reagents person who is presently registered with
    and drug calibrator/controls for DEA DEA to manufacture such a substance
    Tetrahydrocannabionols (7370) ... I exempt products.
    Benzoylecgonine (9180) ............... II may file comments or objections to the
    Morphine (9300) ........................... II Any other such applicant and any issuance of the proposed registration
    person who is presently registered with pursuant to 21 CFR 1301.33(a).
    The company plans to produce the DEA to manufacture such a substance
    may file comments or objections to the Any such written comments or
    listed controlled substances in bulk to objections being sent via regular mail
    be used in the manufacture of reagents issuance of the proposed registration
    pursuant to 21 CFR 1301.33(a). may be addressed, in quintuplicate, to
    and drug calibrator/controls for DEA
    Any such written comments or the Acting Deputy Assistant
    exempt products.
    Any other such applicant and any objections being sent via regular mail Administrator, Office of Diversion
    person who is presently registered with may be addressed, in quintuplicate, to Control, Drug Enforcement
    DEA to manufacture such a substance the Deputy Assistant Administrator, Administration, Washington, DC 20537,
    may file comments or objections to the Office of Diversion Control, Drug Attention: DEA Federal Register
    issuance of the proposed registration Enforcement Administration, Representative, Liaison and Policy
    pursuant to 21 CFR 1301.33(a). Washington, DC 20537, Attention: DEA Section (ODL); or any being sent via
    Any such written comments or Federal Register Representative, Liaison express mail should be sent to DEA
    objections being sent via regular mail and Policy Section (ODL); or any being Headquarters, Attention: DEA Federal
    may be addressed, in quintuplicate, to sent via express mail should be sent to Register Representative/ODL, 2401
    the Deputy Assistant Administrator, DEA Headquarters, Attention: DEA Jefferson Davis Highway, Alexandria,
    Office of Diversion Control, Drug Federal Register Representative/ODL, Virginia 22301; and must be filed no
    Enforcement Administration, 2401 Jefferson Davis Highway, later than January 30, 2006.

    VerDate Aug<31>2005 20:13 Nov 28, 2005 Jkt 208001 PO 00000 Frm 00101 Fmt 4703 Sfmt 4703 E:\FR\FM\29NON1.SGM 29NON1

    You might also like